Company · Ownership research

Travere Therapeutics, Inc. TVTX

CIK 0001438533

Form 4 transactions dated Nov 1, 2023 to Nov 7, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 46 rows; the complete set is available through the API.

Insider filings on file run through Oct 19, 2026.

Insider purchases & sales

Purchased: $0.00
Sold: $125.73M

Nov 1, 2023 – Oct 19, 2026
Available records · partial months are marked ·

202410 of 28 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Dec 26, 2024	Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER	Sale10b5-1 footnote	$258.28K 15,000 shares sold	21.45% sold Direct holding	▾
Nov 25, 2024	Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER	Sale	$221.26K 12,090 shares sold	18.04% sold Direct holding	▾
Oct 4, 2024	LYONS GARY A Director	Sale10b5-1 footnote	$589.10K 40,000 shares sold	43.96% sold Direct holding	▾
Sep 30, 2024	Meckler Jeffrey A Director	Sale10b5-1 footnote	$562.32K 40,000 shares sold	33.06% sold Direct holding	▾
Sep 10, 2024	Inrig Jula CHIEF MEDICAL OFFICER	Sale10b5-1 footnote	$8.88K 684 shares sold	1.09% sold Direct holding	▾
Sep 9, 2024	ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D	Sale10b5-1 footnote	$50.54K 4,387 shares sold	4.94% sold Direct holding	▾
Sep 9, 2024	REED ELIZABETH E SVP, GC & CORPORATE SECRETARY	Sale10b5-1 footnote	$50.54K 4,387 shares sold	5.28% sold Direct holding	▾
Sep 9, 2024	Dube Eric M CHIEF EXECUTIVE OFFICER · Director	Sale10b5-1 footnote	$243.36K 21,125 shares sold	5.51% sold Direct holding	▾
Sep 9, 2024	Inrig Jula CHIEF MEDICAL OFFICER	Sale	$25.24K 2,191 shares sold	3.38% sold Direct holding	▾
Sep 9, 2024	Heerma Peter CHIEF COMMERCIAL OFFICER	Sale	$25.24K 2,191 shares sold	1.99% sold Direct holding	▾

Showing 28 / 28 record groups in 2024. The complete set is available through the API.

Travere Therapeutics, Inc. · TVTX

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 28 of 28 purchase / sale groups and 30 of 46 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"TVTX","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.